Mitigation of Biological Threats through Support for Vaccine Development
Within the Vaccines Partnership (COVAX) of the Access to COVID-19 Tools (ACT)-Accelerator, CEPI is the designated lead for research, development, testing, and licensing of COVID-19 vaccines. The project is managing Canada’s C$60 million contribution to CEPI for COVID-19 vaccines for 2020.
Providers and Implementers ?
|Implementer||Coalition for Epidemic Preparedness Innovations (CEPI)||NGO|
Related Projects & Programs
Parent Program: Coalition for Epidemic Preparedness Innovations Phase II
|Mr Trevor Smith||Head & CWC Point of Contact||
Global Partnership Program